News related to Trileptal (Oxcarbazepine) and/or conditions it is approved for
New indication for VIMPAT®: anti-epileptic drug approved by FDA as monotherapy in the treatment of patients with partial-onset seizures
Source: Epilepsy News From Medical News Today [2014.09.03]
UCB has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VIMPAT® (lacosamide) C-V as monotherapy in the treatment of...
Potential treatments for absence seizures
Source: Epilepsy News From Medical News Today [2014.08.25]
Absence seizures are believed to be elicited by T-type calcium channels in the thalamic reticular nucleus of the brain that regulate influxes of calcium.
Two Drugs Work Equally Well for Epileptic Seizures in Kids: Study
Source: MedicineNet lorazepam Specialty [2014.04.23]
Title: Two Drugs Work Equally Well for Epileptic Seizures in Kids: Study
Category: Health News
Created: 4/22/2014 4:36:00 PM
Last Editorial Review: 4/23/2014 12:00:00 AM
Source: MedicineNet Roseola Specialty [2014.01.15]
Title: Febrile Seizures
Category: Diseases and Conditions
Created: 5/9/2008 12:00:00 AM
Last Editorial Review: 1/15/2014 12:00:00 AM
Omega-3 fish oil 'could reduce seizure frequency for epilepsy patients'
Source: Cardiovascular / Cardiology News From Medical News Today [2014.09.09]
A new study by researchers from UCLA School of Medicine suggests consuming low doses of omega-3 fish oil each day could reduce the occurrence of seizures in patients with epilepsy.
Misdiagnosis common in rheumatologic diseases like lupus
Source: Arthritis / Rheumatology News From Medical News Today [2014.08.20]
Lupus and other rheumatologic diseases can initially present as neurological disorders such as headaches and seizures, and thus delay diagnosis for many months, according to Loyola University Medical...
New real-life and clinical data presented on Vimpat (lacosamide) at the European Congress on Epileptology
Source: Epilepsy News From Medical News Today [2014.07.02]
UCB has announced data from two studies evaluating the efficacy and safety of Vimpat® (lacosamide) as early adjunctive treatment in adults with partial-onset seizures.
Early measles immunization reduces seizure risk
Source: Litigation / Medical Malpractice News From Medical News Today [2013.10.15]
A new study shows that the risk of fever and febrile seizures following a measles vaccination are lower in babies receiving the first dose by the age of 15 months.